Royalty Pharma stockRPRX
Royalty Pharma trades at $67.57, 3.2% below its 52-week high (Nov 5, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +76.6% year to date, +69.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 16, 2027.
Ratings, candles, signals and the screener for RPRX — after you log in
Open the terminalFrequently asked questions about Royalty Pharma
What is the Royalty Pharma stock price?
At the close on Nov 5, 2026: $67.57 (+0.01% on the day). 52-week high: $69.77 on Nov 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Royalty Pharma report earnings?
The next quarterly report is on Feb 16, 2027. Last quarter, earnings per share changed +135% year over year, revenue +9%.
Does Royalty Pharma pay dividends?
Yes, the dividend yield is about 1.40% a year.
Where does Royalty Pharma trade and how to buy it?
Ticker RPRX, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Royalty Pharma now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RPRX are in the terminal after you log in.